Element Biosciences scores $276m Series C

Element Biosciences, a developer of a DNA sequencing platform, has raised $276 million in Series C financing.

Element Biosciences, a developer of a DNA sequencing platform, has raised $276 million in Series C financing. The investors included Janus Henderson Investors, Logos Capital, Meritech Capital Partners, T. Rowe Price, Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock.

Source: Press Release